Clinical features in patients of cough variant asthma with normal and high level of exhaled fractional nitric oxide

Objective Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared. Methods The clinical history and pulmona...

Full description

Saved in:
Bibliographic Details
Published inThe clinical respiratory journal Vol. 12; no. 2; pp. 595 - 600
Main Authors Tang, Wei, Zhou, Jun, Miao, Lili, Shi, GuoCao
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.02.2018
Subjects
Online AccessGet full text
ISSN1752-6981
1752-699X
1752-699X
DOI10.1111/crj.12568

Cover

Abstract Objective Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared. Methods The clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected. Result Newly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n = 52) and a normal FeNO group (FeNO lower than 25 ppb, n = 47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25‐75). There was a significant decrease in FEF25‐75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi‐factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR = 5.03, 95% CI, 1.88‐13.49). Conclusion CVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies.
AbstractList Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared. The clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected. Newly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n = 52) and a normal FeNO group (FeNO lower than 25 ppb, n = 47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25-75). There was a significant decrease in FEF25-75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi-factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR = 5.03, 95% CI, 1.88-13.49). CVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies.
Objective Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared. Methods The clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected. Result Newly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n = 52) and a normal FeNO group (FeNO lower than 25 ppb, n = 47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25‐75). There was a significant decrease in FEF25‐75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi‐factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR = 5.03, 95% CI, 1.88‐13.49). Conclusion CVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies.
Objective Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared. Methods The clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected. Result Newly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n=52) and a normal FeNO group (FeNO lower than 25 ppb, n=47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25-75). There was a significant decrease in FEF25-75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi-factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR=5.03, 95% CI, 1.88-13.49). Conclusion CVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies.
Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared.OBJECTIVECough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients with CVA who had normal and high exhaled fractional nitric oxide (FeNO) levels were compared.The clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected.METHODSThe clinical history and pulmonary function data from 99 patients with newly diagnosed CVA were collected.Newly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n = 52) and a normal FeNO group (FeNO lower than 25 ppb, n = 47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25-75). There was a significant decrease in FEF25-75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi-factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR = 5.03, 95% CI, 1.88-13.49).RESULTNewly diagnosed subjects with CVA were divided into a high FeNO group (FeNO value over or equal to 25 ppb, n = 52) and a normal FeNO group (FeNO lower than 25 ppb, n = 47). There were more patients with coexistent allergic rhinitis or with family histories of allergic diseases in the high FeNO group. More patients in the high FeNO group reported that their chronic cough was triggered by allergen exposure. In the high FeNO group, the patients were younger than in the normal FeNO group. It was shown that baseline lung function tests were normal in all subjects, apart from a reduced midexpiratory flow rate (FEF25-75). There was a significant decrease in FEF25-75 in the high FeNO group compared with the normal FeNO group. No difference was found in the PD20 or the maximal FEV1 drop between the two groups. The multi-factor logistic regression analysis showed that concomitant with allergic rhinitis was the high risk factor of a high FeNO in these subjects with CVA (OR = 5.03, 95% CI, 1.88-13.49).CVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies.CONCLUSIONCVA patients showed heterogeneity according to FeNO level. Patients with high FeNO level are more likely to experience symptoms associated with allergies.
Author Miao, Lili
Tang, Wei
Zhou, Jun
Shi, GuoCao
Author_xml – sequence: 1
  givenname: Wei
  surname: Tang
  fullname: Tang, Wei
  organization: Shanghai Jiaotong University School of Medicine
– sequence: 2
  givenname: Jun
  surname: Zhou
  fullname: Zhou, Jun
  organization: Shanghai Jiaotong University School of Medicine
– sequence: 3
  givenname: Lili
  surname: Miao
  fullname: Miao, Lili
  organization: Yi Zheng People's Hospital
– sequence: 4
  givenname: GuoCao
  surname: Shi
  fullname: Shi, GuoCao
  email: shiguochao@hotmail.com
  organization: Shanghai Jiaotong University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27731932$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1vFCEYh4mpsR968B8wJF70sC0fOwwczaZWmyYmjSbeyLsM47BhYAWmH_99me7WQ1O5wOF5frx5f8foIMRgEXpPySmt58ykzSlljZCv0BFtG7YQSv0--PeW9BAd57whpJEtb96gQ9a2nCrOjlBeeRecAY97C2VKNmMX8BaKs6FkHHts4vRnwDeQHISCIZdhBHzryoBDTGMVIXR4cJXx9sb6WbF3A3jb4T6BKS6GCgVXkjM43rnOvkWve_DZvtvfJ-jX1_Ofq2-Lqx8X31dfrhaGN1wuVMdkt2ZGqKYRgtaBJYHGECmFsr0ykgrTK94C42a5Zk0nekJpB-1SEbtuDT9Bn3a52xT_TjYXPbpsrPcQbJyypnL-p5WcV_TjM3QTp1QHz5oRwoiQSzVTH_bUtB5tp7fJjZDu9dM6K3C2A0yKOSfba-MKzCsoCZzXlOi5MF0L04-FVePzM-Mp9CV2n37rvL3_P6hX15c74wFiX6RP
CitedBy_id crossref_primary_10_1002_alr_23090
crossref_primary_10_1080_02770903_2019_1568452
crossref_primary_10_1155_2021_6694936
crossref_primary_10_1186_s13223_019_0318_5
crossref_primary_10_1097_MD_0000000000026416
crossref_primary_10_1080_00914037_2019_1596917
crossref_primary_10_3389_fmed_2021_727381
crossref_primary_10_4168_aair_2019_11_6_830
Cites_doi 10.1016/j.niox.2014.06.001
10.1183/09031936.00202413
10.1378/chest.12-0441
10.1164/rccm.9120-11ST
10.1056/NEJM197903223001201
10.1016/j.pupt.2008.12.001
10.3109/02770903.2013.878953
10.1016/j.rmed.2008.04.018
10.4168/aair.2016.8.1.12
10.1378/chest.10-0132
10.1016/j.jaci.2014.10.026
10.1159/000355706
10.1016/S0140-6736(08)61420-8
10.1164/rccm.200609-1346OC
10.1186/1465-9921-8-82
10.1152/physrev.00034.2003
10.1111/j.1600-065X.2011.01032.x
10.1016/j.rmed.2012.10.003
10.2500/aap.2007.28.2920
ContentType Journal Article
Copyright 2016 John Wiley & Sons Ltd
2016 John Wiley & Sons Ltd.
Copyright © 2018 John Wiley & Sons Ltd
Copyright_xml – notice: 2016 John Wiley & Sons Ltd
– notice: 2016 John Wiley & Sons Ltd.
– notice: Copyright © 2018 John Wiley & Sons Ltd
DBID AAYXX
CITATION
NPM
K9.
7X8
DOI 10.1111/crj.12568
DatabaseName CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed

ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1752-699X
EndPage 600
ExternalDocumentID 27731932
10_1111_crj_12568
CRJ12568
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OC
24P
29B
31~
3SF
4.4
50Y
50Z
52M
52O
52S
52T
52U
52V
52W
53G
5HH
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
930
A01
A03
AAESR
AAEVG
AAMMB
AANHP
AAONW
AAZKR
ABCUV
ABDBF
ABJNI
ABPVW
ABUWG
ACAHQ
ACBWZ
ACCMX
ACGFS
ACMXC
ACPOU
ACRPL
ACUHS
ACXQS
ACYXJ
ADBBV
ADEOM
ADIYS
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADPDF
ADXAS
ADZMN
AEFGJ
AEIMD
AENEX
AFBPY
AFGKR
AFKRA
AGQPQ
AGXDD
AHMBA
AIACR
AIDQK
AIDYY
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
ESX
F00
F01
F04
F21
F5P
FEDTE
FUBAC
FYUFA
G-S
G.N
GODZA
GROUPED_DOAJ
H.X
HF~
HMCUK
HVGLF
HZ~
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
NF~
O66
O9-
OIG
OK1
OVD
OVEED
P2W
P2X
P2Z
P4D
PQQKQ
Q.N
QB0
R.K
ROL
RPM
RX1
SUPJJ
SV3
TEORI
TUS
UB1
UKHRP
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WVDHM
XG1
ZZTAW
~IA
~WT
AAYXX
CITATION
PHGZM
33P
AAHHS
ACCFJ
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
NPM
K9.
7X8
ID FETCH-LOGICAL-c3538-9d28db2c695566131980a5c08869ef9c816cf937a23c4b25d6f011da7490eb7c3
ISSN 1752-6981
1752-699X
IngestDate Thu Oct 02 10:27:43 EDT 2025
Tue Oct 07 06:06:55 EDT 2025
Wed Feb 19 02:43:13 EST 2025
Wed Oct 01 02:57:02 EDT 2025
Thu Apr 24 22:57:21 EDT 2025
Wed Aug 20 07:24:35 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords exhaled fractional nitric oxide
allergic rhinitis
cough variant asthma
FEF25-75
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2016 John Wiley & Sons Ltd.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3538-9d28db2c695566131980a5c08869ef9c816cf937a23c4b25d6f011da7490eb7c3
Notes All the authors do not have any potential conflicts of interests.
Wei Tang and Jun Zhou contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
PMID 27731932
PQID 2002068493
PQPubID 946373
PageCount 6
ParticipantIDs proquest_miscellaneous_1835387833
proquest_journals_2002068493
pubmed_primary_27731932
crossref_citationtrail_10_1111_crj_12568
crossref_primary_10_1111_crj_12568
wiley_primary_10_1111_crj_12568_CRJ12568
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2018
2018-02-00
2018-Feb
20180201
PublicationDateYYYYMMDD 2018-02-01
PublicationDate_xml – month: 02
  year: 2018
  text: February 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Copenhagen
PublicationTitle The clinical respiratory journal
PublicationTitleAlternate Clin Respir J
PublicationYear 2018
Publisher John Wiley & Sons, Inc
Publisher_xml – name: John Wiley & Sons, Inc
References 2007; 28
2004; 84
1979; 200
2015; 135
2010; 138
2007; 176
2013; 107
2007; 8
2009; 7
2013; 143
2008; 102
2009; 2
2014; 40
2011; 184
2014; 51
2008; 372
2016; 8
2014; 44
2011; 242
2014; 87
e_1_2_10_12_1
e_1_2_10_23_1
e_1_2_10_9_1
e_1_2_10_13_1
e_1_2_10_10_1
e_1_2_10_21_1
e_1_2_10_11_1
e_1_2_10_22_1
e_1_2_10_20_1
Chinese Medical A. (e_1_2_10_8_1) 2009; 7
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_14_1
e_1_2_10_7_1
e_1_2_10_15_1
References_xml – volume: 8
  start-page: 82
  year: 2007
  article-title: Factors affecting exhaled nitric oxide measurements: the effect of sex
  publication-title: Respir Res.
– volume: 84
  start-page: 731
  year: 2004
  end-page: 765
  article-title: Nitric oxide in health and disease of the respiratory system
  publication-title: Physiol Rev.
– volume: 138
  start-page: 1418
  issue: 6
  year: 2010
  end-page: 1425
  article-title: Inflammatory subtypes in cough‐variant asthma: association with maintenance doses of inhaled corticosteroids
  publication-title: Chest.
– volume: 176
  start-page: 238
  year: 2007
  end-page: 242
  article-title: Reference ranges for exhaled nitric oxide derived from a random community survey of adults
  publication-title: Am J Respir Crit Care Med.
– volume: 28
  start-page: 74
  issue: 1
  year: 2007
  end-page: 78
  article-title: Role of forced expiratory flow at 25‐75% as an early marker of small airways impairment in subjects with allergic rhinitis
  publication-title: Allergy Asthma Proc.
– volume: 200
  start-page: 633
  year: 1979
  end-page: 637
  article-title: Chronic cough as the sole presenting manifestation of bronchial asthma
  publication-title: N Engl J Med.
– volume: 102
  start-page: 1452
  year: 2008
  end-page: 1459
  article-title: Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough
  publication-title: Respir Med.
– volume: 51
  start-page: 411
  issue: 4
  year: 2014
  end-page: 416
  article-title: FENO and AHR mannitol in patients referred to an out‐of‐hospital asthma clinic: a real‐life study
  publication-title: J Asthma.
– volume: 372
  start-page: 1015
  issue: 9643
  year: 2008
  end-page: 1017
  article-title: Exhaled nitric oxide in guideline‐based asthma management
  publication-title: Lancet.
– volume: 143
  start-page: 613
  issue: 3
  year: 2013
  end-page: 620
  article-title: A prospective, multicenter survey on causes of chronic cough in China
  publication-title: Chest.
– volume: 2
  start-page: 114
  issue: 2
  year: 2009
  end-page: 120
  article-title: Eosinophilic airway disorders associated with chronic cough
  publication-title: Pulmon Pharmacol Therap.
– volume: 102
  start-page: 1452
  issue: 10
  year: 2008
  end-page: 1459
  article-title: Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough
  publication-title: Respir Med.
– volume: 135
  start-page: 877
  issue: 4
  year: 2015
  end-page: 883
  article-title: Biomarker‐based asthma phenotypes of corticosteroid response
  publication-title: J Allergy Clin Immunol.
– volume: 107
  start-page: 209
  issue: 2
  year: 2013
  end-page: 216
  article-title: FENO measurement and sputum analysis for diagnosing asthma in clinical practice
  publication-title: Respir Med.
– volume: 40
  start-page: 87
  year: 2014
  end-page: 91
  article-title: Predictive value of fractional nitric oxide in asthma diagnosis‐subgroup analyses
  publication-title: Nitric Oxide.
– volume: 7
  start-page: 453
  issue: 5
  year: 2009
  end-page: 456
  article-title: Diagnosis and treatment guideline of cough
  publication-title: Clin Educ Gen Pract (Chin).
– volume: 184
  start-page: 602
  issue: 5
  year: 2011
  end-page: 615
  article-title: An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications
  publication-title: Am J Respir Crit Care Med.
– volume: 44
  start-page: 351
  issue: 2
  year: 2014
  end-page: 360
  article-title: Exhaled nitric oxide, nitrite/nitrate levels, allergy, rhinitis and asthma in the EGEA study
  publication-title: Eur Respir J.
– volume: 87
  start-page: 211
  issue: 3
  year: 2014
  end-page: 218
  article-title: Prevalence and clinical relevance of allergic rhinitis in patients with classic asthma and cough variant asthma
  publication-title: Respiration.
– volume: 8
  start-page: 12
  issue: 1
  year: 2016
  end-page: 21
  article-title: Exhaled NO: determinants and clinical application in children with allergic airway disease
  publication-title: Allergy Asthma Immunol Res.
– volume: 242
  start-page: 220
  issue: 1
  year: 2011
  end-page: 232
  article-title: Human asthma phenotypes: from the clinic, to cytokines, and back again
  publication-title: Immunol Rev.
– ident: e_1_2_10_4_1
  doi: 10.1016/j.niox.2014.06.001
– ident: e_1_2_10_20_1
  doi: 10.1183/09031936.00202413
– ident: e_1_2_10_2_1
  doi: 10.1378/chest.12-0441
– ident: e_1_2_10_11_1
  doi: 10.1164/rccm.9120-11ST
– ident: e_1_2_10_9_1
  doi: 10.1056/NEJM197903223001201
– ident: e_1_2_10_3_1
  doi: 10.1016/j.pupt.2008.12.001
– ident: e_1_2_10_16_1
  doi: 10.3109/02770903.2013.878953
– volume: 7
  start-page: 453
  issue: 5
  year: 2009
  ident: e_1_2_10_8_1
  article-title: Diagnosis and treatment guideline of cough
  publication-title: Clin Educ Gen Pract (Chin).
– ident: e_1_2_10_12_1
  doi: 10.1016/j.rmed.2008.04.018
– ident: e_1_2_10_10_1
– ident: e_1_2_10_19_1
  doi: 10.4168/aair.2016.8.1.12
– ident: e_1_2_10_14_1
  doi: 10.1378/chest.10-0132
– ident: e_1_2_10_5_1
  doi: 10.1016/j.jaci.2014.10.026
– ident: e_1_2_10_22_1
  doi: 10.1159/000355706
– ident: e_1_2_10_6_1
  doi: 10.1016/S0140-6736(08)61420-8
– ident: e_1_2_10_18_1
  doi: 10.1164/rccm.200609-1346OC
– ident: e_1_2_10_21_1
  doi: 10.1186/1465-9921-8-82
– ident: e_1_2_10_7_1
  doi: 10.1152/physrev.00034.2003
– ident: e_1_2_10_17_1
  doi: 10.1016/j.rmed.2008.04.018
– ident: e_1_2_10_13_1
  doi: 10.1111/j.1600-065X.2011.01032.x
– ident: e_1_2_10_15_1
  doi: 10.1016/j.rmed.2012.10.003
– ident: e_1_2_10_23_1
  doi: 10.2500/aap.2007.28.2920
SSID ssj0058735
Score 2.1614203
Snippet Objective Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in...
Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in patients...
Objective Cough variant asthma (CVA) is a subtype of asthma that is characterized by a chronic cough. The clinical characteristics and pulmonary function in...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 595
SubjectTerms allergic rhinitis
Asthma
cough variant asthma
exhaled fractional nitric oxide
FEF25‐75
Nitric oxide
Title Clinical features in patients of cough variant asthma with normal and high level of exhaled fractional nitric oxide
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcrj.12568
https://www.ncbi.nlm.nih.gov/pubmed/27731932
https://www.proquest.com/docview/2002068493
https://www.proquest.com/docview/1835387833
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1752-699X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0058735
  issn: 1752-6981
  databaseCode: ABDBF
  dateStart: 20070701
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVOVD
  databaseName: Journals@Ovid LWW All Open Access Journal Collection Rolling
  customDbUrl:
  eissn: 1752-699X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0058735
  issn: 1752-6981
  databaseCode: OVEED
  dateStart: 20070701
  isFulltext: true
  titleUrlDefault: http://ovidsp.ovid.com/
  providerName: Ovid
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLaGqYS4IHYGCjKIA1KVynESxzm2A1VVaThAK3qLvEUdaZqgWVDFf-A_82wnToa2UuESRYk9duZ9fov9FoQ-SKIrJhSPKk54lFa5iLiiWSTAZtZcEkmENRRnX9jxWXpynp2PRr8HXkubtdxXv26MK_kfqsIzoKuNkv0HyoYfhQdwD_SFK1AYrnei8bQLa6yMy8_pfcJ9ptSVdxi3NXh-gj0srCv5an1xKfzWa211VZ8mwGYs3ltY5yHbxVxdgMzQe9XShzxAI1j11t--uZrrLcchC7EQWbkcnNkPJ-92BTxD-W7m_T51s_FBIQGcs7lo_C7BIjT75koOA46bqWiGGxQx73yaA0_NMxqxwldm2TfDZ66Kbs-I6QBwdMBVM1-HsxXQzKU2vY33qyVwf9DjeC_gukP9v-Re8Ebs7CDoWrqu99AOBSFBxmjn4PDT4VEn2jOeu4qt4YvaVFXWNSyMu63gXLNato0gp8WcPkIPW_MDH3gsPUYjUz9B92etg8VTtOoghTtI4XmNO0jhpsIOUriFFPaQwhZS2EMKA6SwhRR2kLJdWkjhHlLYQwo7SD1DZ0efT6fHUVuXI1KJk4-aci2pYkUGxkAMTJwTkSmQV6wwVaF4zFQFaq-giUolzTSrQIpokacFMTJXyXM0rpvavERYJ1XCiTRxplXKEiJjW19eFkozJYhKJ-hj92eWqk1ab2unLMprRJug96HpD5-p5aZGux1FynYtrGwlVkoYT4tkgt6F18Bm7dmZqE2zWZUg-eDTc55AmxeekmEUmueJtYNgso60tw9fTr-euJtXd5nsa_SgX0-7aLxebswbUIHX8m0LzD-937PW
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+features+in+patients+of+cough+variant+asthma+with+normal+and+high+level+of+exhaled+fractional+nitric+oxide&rft.jtitle=The+clinical+respiratory+journal&rft.au=Tang%2C+Wei&rft.au=Zhou%2C+Jun&rft.au=Miao%2C+Lili&rft.au=Shi%2C+GuoCao&rft.date=2018-02-01&rft.issn=1752-6981&rft.eissn=1752-699X&rft.volume=12&rft.issue=2&rft.spage=595&rft.epage=600&rft_id=info:doi/10.1111%2Fcrj.12568&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_crj_12568
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1752-6981&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1752-6981&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1752-6981&client=summon